Amrutanjan Health Care Ltd

Amrutanjan Health Care Limited's investor presentation for the quarter ended June 30, 2026, reported a 9.48% growth in net sales, reaching ₹102.97 crores compared to ₹94.05 crores in the same quarter last year. The women's hygiene segment showed robust growth, with a 27.09% increase in net sales, while the pain management category faced a decline of 3.4% in volume growth. Management highlighted that 65% of revenue comes from pain management, which has been impacted by retailer demand erosion and high base effects. New product launches, including women's and men's razors, contributed to overall sales, and a new sanitary napkin manufacturing facility was commissioned in Telangana. Management noted that one-time charges from the previous year would not recur, and they expressed confidence in achieving double-digit growth in revenue and operating profits for the year.

The presentation included both positive growth metrics and challenges in key segments.